Article

BPEI to aid quake victims in Japan

The Bascom Palmer Eye Institute (BPEI) of the University of Miami Miller School of Medicine and Keio University School of Medicine in Tokyo have launched a Japan Eye Rescue Mission to assist that country with recovery from the Tohoku-Pacific Ocean Earthquake.

Miami-The Bascom Palmer Eye Institute (BPEI) of the University of Miami Miller School of Medicine and Keio University School of Medicine in Tokyo have launched a Japan Eye Rescue Mission to assist that country with recovery from the Tohoku-Pacific Ocean earthquake.

The relief operations began April 12 as the institute’s Vision Van departed on a cargo flight from Miami International Airport to Sendai, Japan. This trip marks the Vision Van’s first international rescue mission, and it is expected to stay abroad for about 3 months.

The 40-foot converted bus contains a waiting room, three screening stations, an exam room, and ophthalmic equipment. For this trip, it is stocked with more than 1,000 ready-made lenses, donated by Eye Care Centers of America, to treat a wide range of prescription needs for people who lost or broke their eyeglasses.

While the van is in Japan, Keio University ophthalmologists and trained volunteers will use it to offer emergency vision screenings and treatments for people suffering from eye injuries incurred during or after the earthquake, to treat infections and inflammations from contaminated water and other hazards, and to replace eyeglasses lost while people were fleeing the earthquake.

Making the trip from the United States is Richard Lee, MD, PhD, associate professor of ophthalmology at the BPEI. He will provide training based on his experience with the institute’s relief work in Haiti.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.